Laurent Pharmaceuticals Announces Phase 2 Clinical Trial results

Written By Sondra Pierson

Laurent Pharmaceuticals Announces Topline Results from its Phase 2 RESOLUTION Clinical Trial of LAU-7b for the Treatment of COVID-19. Click here for the full Press Release.

Sondra Pierson
Previous

Venture Pitch Night Winners
Next

Windgap medical Inc. raises $17M Series B Investment